US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 3.940
  • -0.180-4.37%
Close Nov 21 16:00 ET
  • 3.990
  • +0.050+1.27%
Post 20:01 ET
210.28MMarket Cap-4147P/E (TTM)

About TScan Therapeutics Company

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.

Company Profile

SymbolTCRX
Company NameTScan Therapeutics
Listing DateJul 16, 2021
Issue Price15.00
Founded2018
CEODr. Gavin MacBeath, PhD
MarketNASDAQ
Employees154
Fiscal Year Ends12-31
Address830 Winter Street
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-857-399-9500
Websitehttp://www.tscan.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Gavin MacBeath, PhD
  • Chief Executive Officer and Director
  • 3.20M
  • Dr. Zoran Zdraveski
  • Chief Legal and Strategy Officer and Secretary
  • 1.58M
  • Jason A. Amello
  • Treasurer, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Chrystal U. Louis, M.D.
  • Chief Medical Officer
  • --
  • Leiden Dworak
  • Vice President, Finance
  • --
  • Dr. Stephen R. Biggar,M.D.,PhD
  • Chairman of the Board
  • 123.17K
  • Katina Dorton, J.D.,M.B.A.
  • Independent Director
  • 132.59K
  • Dr. Barbara Klencke, M.D.
  • Independent Director
  • 121.74K
  • Robert Keith Woods
  • Independent Director
  • 90.90K
  • Dr. Gabriela Gruia, M.D.
  • Independent Director
  • 113.53K
  • Garry A. Nicholson
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data